GlobeNewswire Inc.··NaDisc Medicine to Present Breakthrough Anemia Data for DISC-0974 at ASCO 2026
Disc Medicine to present Phase 2 DISC-0974 data showing unprecedented anemia response rates in myelofibrosis at ASCO 2026, potentially reshaping treatment landscape.
IRONphase 2 trialclinical trial data